Fate Therapeutics Long Term Deferred Tax Liabilities (Quarterly) Trends

Fate Therapeutics, Inc. (FATE)

1.63 +0.12 (+7.95%) USD | NASDAQ | Feb 24, 16:00

1.63 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Tax Liabilities (Quarterly) for FATE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Tax Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Tax Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Tax Liabilities (Quarterly) Benchmarks

Start Trial

MannKind Corp.	--
Vertex Pharmaceuticals, Inc.	Upgrade
Ardelyx, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade